Related Experiment Video

Updated: May 10, 2026

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
08:01

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Published on: May 16, 2021

AMP-activated protein kinase: a target for old drugs against diabetes and cancer

Gian Luigi Russo1, Maria Russo, Paola Ungaro

  • 1Institute of Food Sciences, National Research Council, 83100 Avellino, Italy. glrusso@isa.cnr.it

Biochemical Pharmacology
|June 11, 2013
PubMed

Insights

AMP-activated protein kinase (AMPK) is crucial for cellular energy balance and protects against metabolic diseases and cancer. Activating AMPK with compounds may prevent chronic diseases and promote healthy aging.

Area of Science:

  • Biochemistry
  • Cellular Metabolism
  • Physiology

Background:

  • AMP-activated protein kinase (AMPK) is a critical regulator of cellular energy homeostasis.
  • AMPK functions as an αβγ heterotrimer, regulated by nucleotides and phosphorylation, with Thr172 phosphorylation on the α-subunit being vital for activation.
  • AMPK plays significant roles in metabolic diseases like type 2 diabetes and in cancer progression.

Purpose of the Study:

  • To review recent findings on the role and function of AMPK in normal physiology and pathological conditions.
  • To discuss the therapeutic potential of AMPK activation in metabolic diseases and cancer.
  • To explore the use of naturally occurring compounds for AMPK activation to prevent chronic diseases.

Main Methods:

  • Review of recent scientific literature and findings on AMPK.
  • Analysis of AMPK's regulatory mechanisms, including allosteric regulation and phosphorylation.
  • Discussion of pharmacological and natural compound-mediated AMPK activation strategies.

Main Results:

  • AMPK activation is essential for cellular energy balance and acts as a protective mechanism against energy stress.
  • Pharmacological activation of AMPK, e.g., by metformin, shows potential in reversing metabolic abnormalities in type 2 diabetes.
  • Targeting the LKB1/AMPK/mTORC1 pathway can mitigate the Warburg effect in cancer, positioning AMPK as a therapeutic target.

Conclusions:

  • AMPK is a central player in maintaining energy homeostasis and has implications in diabetes and cancer.
  • Activating AMPK through pharmacological or natural compounds offers a promising strategy for managing metabolic disorders and cancer.
  • Targeted AMPK activation may contribute to chronic disease prevention and promote healthy aging.
Keywords:
AMP-activated protein kinaseAdenylate energy chargeBiguanidesCancerDiabetesEnergy metabolic stressNatural compounds

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...